GTx Inc Recovers Slightly on the Market Today After a Disastrous September
GTx Inc. (NASDAQ:GTXI) is a biopharmaceutical company that is headquartered in Memphis, Tennessee, and was founded in 1997. The company focuses on discovering and developing medicines in the treatment of stress urinary incontinence (SUI) and …
ProQR Therapeutics Jumps 60% on Favorable Clinical News
Every day, biotech companies are fighting to make the world a better, healthier, and safer place, and if releasing favorable clinical trial news makes shares jump, then that’s a bonus. Today, this happened after results …
Bellerophon Stock Plunges 68% After Committee Terminates INOpulse Study
The biotechnology industry can be a tough one. When trials are a success, a company’s stock flies. However, the opposite can occur when trials get rejected. On Tuesday, the latter happened to Bellerophon Therapeutics. After …
Progenics Pharmaceuticals’ Stock Gets an 8% Boost After FDA Approval
Progenics Pharmaceuticals receives FDA approval for the first drug to treat rare and extremely life-threatening cancers in patients 12 and older. This approval has boosted the company’s stock exponentially on today’s market.
Progenics Pharmaceuticals … Read
Tonix Pharmaceuticals Holding Corp Falls Nearly 70% Today
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) announced this morning that it would be halting its Phase 3 study of its Tonmya drug, which caused its stock price to drop in dramatic fashion.
After its …
resTORbio Inc’s Positive Phase 2b Trial Results Boost Stock 50%
Shares of resTORbio Inc (NASDAQ:TORC) jumped today after the company announced via press release the results of its phase 2 clinical study. The small biotech company has the drug RTB101, which is used to treat …
FDA Waives BioPharmX Corporation’s Study and Stock Jumps 16%
FDA waives BioPharmX study, in what many would consider a huge break for the company.
FDA Waives BioPharmX Study
The Palo Alto-based specialty pharmaceutical company that develops products for dermatologists announced via press …
FDA: CTI BioPharma Must Conduct A Third Pacritinib Phase 3 Study
Today, the FDA requested a third CTI BioPharma Pacritinib phase 3 study. Usually, getting approval from the FDA to start a phase 3 clinical trial on a drug is a good thing. It’s not a …
Shares of Fluoropharma Medical Inc Rally 37.5%
Shares of Fluoropharma Medical Inc. (OTCQB:FPMI) have risen a whopping 37.5% on the news that the company has acquired an exclusive option to license meta-Fluorobenzylguanidine (MFBG). MFBG is an imaging agent which has been acquired …
MariMed Shares are Booming Despite Sideways Movement in the Marijuana Index
MariMed Inc (OTCQB:MRMD): MariMed shares are gaining positive momentum since the start of this year albeit sideways movement in the marijuana index. The North American marijuana index remains range-bound over the last two months after …